Jad Othman
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 38
- Acute Myeloid Leukemia Research 35
- Chronic Myeloid Leukemia Treatments 12
- Hematopoietic Stem Cell Transplantation 6
- Genetics 13
- Chronic Lymphocytic Leukemia Research 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Co-authors
- Richard James Dillon (14 shared papers)Nicola E. Potter (10 shared papers)Nigel H. Russell (11 shared papers)Jelena V. Jovanovic (6 shared papers)Amanda Gilkes (9 shared papers)Richard J. Coffey (1 shared paper)Adam Ivey (3 shared papers)Ian C. Thomas (2 shared papers)
- Journals
- Blood (17 papers)HemaSphere (5 papers)Blood Advances (4 papers)Transplantation and Cellular Therapy (3 papers)The Lancet Haematology (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Jad Othman
52 papers receiving 687 citations
Peers
Comparison fields: 5 of 54
- Hematology 490
- Genetics 133
- Public Health, Environmental and Occupational Health 93
- Emergency Medicine 24
- Oncology 63
Countries citing papers authored by Jad Othman
This map shows the geographic impact of Jad Othman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jad Othman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jad Othman more than expected).
Fields of papers citing papers by Jad Othman
This network shows the impact of papers produced by Jad Othman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jad Othman. The network helps show where Jad Othman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jad Othman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 66 | |
| 2 | 2021 | 59 | |
| 3 | 2023 | 56 | |
| 4 | 2024 | 56 | |
| 5 | 2024 | 54 | |
| 6 | 2023 | 45 | |
| 7 | 2023 | 37 | |
| 8 | 2022 | 35 | |
| 9 | 2024 | 27 | |
| 10 | 2023 | 24 | |
| 11 | 2024 | 21 | |
| 12 | 1995 | 19 | |
| 13 | 2024 | 18 | |
| 14 | 2025 | 14 | |
| 15 | 2020 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2020 | 11 | |
| 18 | 2018 | 10 | |
| 19 | 2017 | 9 | |
| 20 | 2021 | 9 |
About Jad Othman
Jad Othman is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Epidemiology, having authored 59 papers that have together received 702 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (35 papers), Chronic Myeloid Leukemia Treatments (12 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Vascular Tumors and Angiosarcomas (5 papers), Histone Deacetylase Inhibitors Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (490 citations), Genetics (133 citations), Public Health, Environmental and Occupational Health (93 citations), Emergency Medicine (24 citations) and Oncology (63 citations). Jad Othman has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Richard James Dillon, Nicola E. Potter, Nigel H. Russell, Jelena V. Jovanovic, Amanda Gilkes, Richard J. Coffey, Adam Ivey, Ian C. Thomas, Manohursingh Runglall and Sean J. Johnson. Their work appears in journals such as Blood, HemaSphere, Blood Advances, Transplantation and Cellular Therapy and The Lancet Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.